Plus   Neg

Brenntag Q2 Sales Down

Brenntag AG (BNTGF.PK) Thursday announced second-quarter preliminary sales of about 2.82 billion euros, down 12.9% on a constant currency basis from last year.

Preliminary operating EBITDA for the second quarter is around 276 million euros, which represents a rise of 4.0% from a year ago.

Preliminary operating gross profit for the second quarter is around 716 million euros, which is roughly in line with the prior-year figure.

Preliminary earnings were 0.80 per share, which is 1.2% below last year's figure.

The company said that despite the significant impacts of the global COVID-19 pandemic, in the first six months of 2020 the company managed to keep the business almost fully operational.

Moving ahead, the company said the financial year remains uncertain due to the continuing expected effects of the COVID-19 pandemic.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT